Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Stem Cell Therapeutics logo — company profile

Stem Cell Therapeutics

Founded 2004 Post Ipo Equity Total: $33.00M Biopharma, Biotechnology +1

General Information

Company Name Stem Cell Therapeutics
Founded Year 2004
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Post Ipo Equity
Social

Get notified when Stem Cell Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stem Cell Therapeutics

Stem Cell Therapeutics Corp. (TSX-V: SSS), a Toronto-based biopharmaceutical development company, is Canada’s sole publicly-traded firm focused on progressing cancer stem cell breakthroughs into new and innovative cancer treatments. With a foundation of over 50 years of pioneering Canadian stem cell research, the company benefits from strong connections to several Toronto academic institutes and oncology treatment centers, forming one of the world's most prestigious cancer research hubs. Stem Cell Therapeutics Corp. was founded in 2004 and operates within the biopharma and biotechnology industries. The company's last investment of $33.00M was in Post-IPO Equity on 16 December 2013. The investment was made by Ridgeback Capital, VenBio Partners, Sabby Capital, Special Situations Funds, HSMR Advisors, and Merlin Nexus.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• 6
Investor Investor Investor Investor
•••• •••• 		16 Dec 2013

Stem Cell Therapeutics Alternatives & Competitors

Stem Cell Therapeutics vs
ImmunoCellular Therapeutics Ltd
ImmunoCellular Therapeutics Ltd United States

Pioneering immune-based therapies to harness the body's defenses against cancer through advanced imm...

Grant
11 employees
Biotechnology, Health Care
Stem Cell Therapeutics vs
Tract Bio
Tract Bio United States

Discovering and developing novel therapies to transform the treatment of cancer and inflammatory dis...

2 employees
Health and Wellness, Life Sciences
Stem Cell Therapeutics vs
Clade Therapeutics
Clade Therapeutics United States

Clade Therapeutics is a well-funded cell therapy company developing novel cell-based medicines for t...

Series A
14 employees
Biotechnology, Health Care

FAQ About Stem Cell Therapeutics

Stem Cell Therapeutics Corp. (TSX-V: SSS), a Toronto-based biopharmaceutical development company, stands as Canada’s sole publicly-traded firm focused on progressing cancer stem cell breakthroughs into new and innovative cancer treatments. With a foundation of over 50 years of pioneering Canadian st...
Stem Cell Therapeutics was founded in 2004.
Stem Cell Therapeutics operates in the following industries: Biopharma, Biotechnology, Health and Wellness.
Stem Cell Therapeutics has completed 1 funding round, raising a total of $33.00M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Stem Cell Therapeutics include ImmunoCellular Therapeutics Ltd, Tract Bio, Clade Therapeutics, Parse Biosciences, Deverra Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stem Cell Therapeutics and ImmunoCellular Therapeutics Ltd are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stem Cell Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy